Please use this identifier to cite or link to this item:
|Title:||A new efficient method to detect genetic interactions for lung cancer GWAS|
Duell, Eric J.
Christiani, David C.
Schabath, Matthew B.
Arnold, Susanne M.
Thornquist, Mark D.
MacKenzie, Todd A
Amos, Christopher I.
|Keywords:||Càncer de pulmó|
|Abstract:||Background: Genome-wide association studies (GWAS) have proven successful in predicting genetic risk of disease using single-locus models; however, identifying single nucleotide polymorphism (SNP) interactions at the genomewide scale is limited due to computational and statistical challenges. We addressed the computational burden encountered when detecting SNP interactions for survival analysis, such as age of disease-onset. To confront this problem, we developed a novel algorithm, called the Efcient Survival Multifactor Dimensionality Reduction (ES-MDR) method, which used Martingale Residuals as the outcome parameter to estimate survival outcomes, and implemented the Quantitative Multifactor Dimensionality Reduction method to identify signifcant interactions associated with age of disease-onset. Methods: To demonstrate efcacy, we evaluated this method on two simulation data sets to estimate the type I error rate and power. Simulations showed that ES-MDR identifed interactions using less computational workload and allowed for adjustment of covariates. We applied ES-MDR on the OncoArray-TRICL Consortium data with 14,935 cases and 12,787 controls for lung cancer (SNPs=108,254) to search over all two-way interactions to identify genetic interactions associated with lung cancer age-of-onset. We tested the best model in an independent data set from the OncoArray-TRICL data. Results: Our experiment on the OncoArray-TRICL data identifed many one-way and two-way models with a singlebase deletion in the noncoding region of BRCA1 (HR 1.24, P=3.15×10–15), as the top marker to predict age of lung cancer onset. Conclusions: From the results of our extensive simulations and analysis of a large GWAS study, we demonstrated that our method is an efcient algorithm that identifed genetic interactions to include in our models to predict survival outcomes.|
|Note:||Reproducció del document publicat a: https://doi.org/10.1186/s12920-020-00807-9|
|It is part of:||BMC Medical Genomics, 2020, vol. 13|
|Appears in Collections:||Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))|
This item is licensed under a Creative Commons License